It's Complicated: FDA Prohibits CBD In Supplements, Enforcement Priority On Disease Claims
This article was originally published in The Rose Sheet
Executive Summary
As FDA announces its first-ever approval of a drug that contains a substance derived from marijuana, officials say the agency's policy that prohibits CBD's use in dietary supplements or food will not change. They also say, however, that FDA's priority for enforcement actions against dietary supplements containing CBD, an extract from cannabis and hemp plants, will remain on products marketed with drug or disease claims.
You may also be interested in...
De-scheduling Hemp As Controlled Substance Left Behind Clouds Of Confusion Despite Being Lawful
While 2018 farm bill removed hemp –from US list of controlled substances, it sustained prohibition against participation in hemp production by convicted felons who’ve completed their sentences.
Will DEA Saying Synthetic THCs Are Controlled Substances Help Deliver Lawful Hemp Answer?
DEA’s explanation delta-8 THC acetate isn’t hemp, along with FDA’s hemp and cannabis policies chief saying it and other cannabis derivatives aren’t hemp, should simplify decision on lawful use of hemp in non-drug products subject to FDA’s regulatory oversight.
Solving US Hemp Regulatory Problem Will Take Wider View Of FDA Rule – AHPA’s McGuffin
FDA, along with supplement and food industries, have looked to Congress to authorizing agency to waive exclusion rule for hemp ingredients. Instead, Michael McGuffin recommends amending DSHEA to clarify that the same ingredients at different concentrations can be allowed in supplements and drugs.